Marie-claude Gingras PhD

Marie-Claude Gingras is a faculty member of the Human Genome Sequencing Center (HGSC) at Baylor College of Medicine (BCM) since 2005, her research has been primarily focused on cancerous and pre-cancerous gastrointestinal diseases. She collaborated on several genetic studies with the Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) related to pancreatic ductal adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (PNET), intraductal papillary mucinous neoplasm (IPMN), cholangiocarcinoma, and hepatocellular carcinoma (HCC). Moreover, she led an international study on periampullary tumors including ampullary and duodenal adenocarcinoma and distant cholangiocarcinoma. In collaboration with surgeons, she helped establish deidentified biobanks of human pancreatic and hepatic tumor samples.

Marie-Claude Gingras mentors and supervises international PhD students during their research training at the HGSC. She is the director of the Nucleic Acid Laboratory where blood, saliva, cell culture, and FFPE, fresh, or frozen tissue of different origins from cancer patients, individuals with Mendelian and genetic diseases, normal controls, primates, and other organisms, are received, processed for nucleic acid isolation, and entered in the HGSC sequencing pipeline. She is also a scientist entrepreneur, being the cofounder of BioPROVAR corporation, a company dedicated to commercializing BioTremvarTM, a human regulator of inflammation that she discovered and is now patented in several countries.